Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
DEL PRIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership350,571 shares
Latest Disclosed Value $ 8,031,581
Jpmorgan Chase & Co ownership in HVE / Innoviva, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 350,571 shares of Innoviva, Inc. (DE:HVE) valued at $7,011,420 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 149,802 shares of Innoviva, Inc.. This represents a change in shares of 134.02% during the quarter. The current value of the position is $6,730,963 USD.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (HVE) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:HVE / Innoviva, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 INNOVIVA COMMON 45781M101 350,571 200,769 134.02 8,032 168.24 0.0001
2026-05-13 2026-03-31 13F INNOVIVA COMMON 45781M101 0 -100.00 0
2026-02-11 2025-12-31 13F INNOVIVA COMMON 45781M101 149,802 -69,161 -31.59 2,995 -25.08 0.0002
2025-11-26 2025-09-30 13F/A-1 INNOVIVA COMMON 45781M101 218,963 -30,435 -12.20 3,996 -20.24 0.0002
2025-11-07 2025-09-30 13F INNOVIVA COMMON 45781M101 218,963 -30,435 3,996 0.0000
2025-08-12 2025-06-30 13F INNOVIVA COMMON 45781M101 249,398 -41,509 -14.27 5,010 -5.01 0.0003
2025-05-12 2025-03-31 13F INNOVIVA COMMON 45781M101 290,907 6,521 2.29 5,274 6.89 0.0004
2025-02-12 2024-12-31 13F INNOVIVA COMMON 45781M101 284,386 -293,857 -50.82 4,934 -55.81 0.0004
2024-12-26 2024-09-30 13F/A-1 INNOVIVA COMMON 45781M101 578,243 72,039 14.23 11,166 34.50 0.0008
2024-11-08 2024-09-30 13F INNOVIVA COMMON 45781M101 578,243 72,039 11,166 0.0009
2024-12-26 2024-06-30 13F/A-1 INNOVIVA COMMON 45781M101 506,204 368,845 268.53 8,302 296.61 0.0007
2024-08-12 2024-06-30 13F INNOVIVA COMMON 45781M101 506,204 368,845 8,302 0.0007
2024-12-26 2024-03-31 13F/A-1 INNOVIVA COMMON 45781M101 137,359 123,307 877.50 2,093 3,637.50 0.0002
2024-05-10 2024-03-31 13F INNOVIVA COMMON 45781M101 137,359 123,307 2,093 0.0002
2024-12-26 2023-12-31 13F/A-1 THESEUS PHARMACEUTICALS COMMON 88369M101 14,052 911 6.93 57 60.00 0.0000
2024-12-26 2023-12-31 13F/A-1 INNOVIVA COMMON 45781M101 329,207 5,280
2024-02-12 2023-12-31 13F THESEUS PHARMACEUTICALS COMMON 88369M101 14,052 911 57 0.0000
2024-02-12 2023-12-31 13F INNOVIVA COMMON 45781M101 329,207 9,006 5,280 0.0005
2023-11-14 2023-09-30 13F THESEUS PHARMACEUTICALS COMMON 88369M101 13,141 -2,572 -16.37 35 -76.03 0.0000
2023-11-14 2023-09-30 13F INNOVIVA COMMON 45781M101 320,201 -1,974 4,159 0.0005
2023-08-11 2023-06-30 13F THESEUS PHARMACEUTICALS COMMON 88369M101 15,713 2,676 20.53 147 25.86 0.0000
2023-08-11 2023-06-30 13F INNOVIVA COMMON 45781M101 322,175 22,242 4,101 0.0004
2023-05-18 2023-03-31 13F/A-1 THESEUS PHARMACEUTICALS COMMON 88369M101 13,037 3,398 35.25 116 0.0000
2023-05-18 2023-03-31 13F/A-1 INNOVIVA COMMON 45781M101 299,933 -35,643 3,374 0.0004
2023-05-11 2023-03-31 13F THESEUS PHARMACEUTICALS COMMON 88369M101 21 -9,618 0 0.0000
2023-05-11 2023-03-31 13F INNOVIVA COMMON 45781M101 220,701 -114,875 2,829 0.0000
2023-02-13 2022-12-31 13F THESEUS PHARMACEUTICALS COMMON 88369M101 9,639 480 5.24 0 -100.00 0.0000
2023-02-13 2022-12-31 13F INNOVIVA COMMON 45781M101 335,576 26,518 4 0.0006
2022-11-14 2022-09-30 13F THESEUS PHARMACEUTICALS COMMON 88369M101 9,159 75 0.83 53 6.00 0.0000
2022-11-14 2022-09-30 13F INNOVIVA COMMON 45781M101 309,058 -67,942 3,587 0.0005
2022-08-11 2022-06-30 13F THESEUS PHARMACEUTICALS COMMON 88369M101 9,084 3,687 68.32 50 -19.35 0.0000
2022-08-11 2022-06-30 13F INNOVIVA COMMON 45781M101 377,000 70,203 5,564 0.0008
2022-05-11 2022-03-31 13F THESEUS PHARMACEUTICALS COMMON 88369M101 5,397 289 5.66 62 -4.62 0.0000
2022-05-11 2022-03-31 13F INNOVIVA COMMON 45781M101 306,797 27,181 5,936 0.0007
2022-02-11 2021-12-31 13F/A-1 THESEUS PHARMACEUTICALS COMMON 88369M101 5,108 -236,351 -97.88 65 -98.39 0.0000
2022-02-11 2021-12-31 13F/A-1 INNOVIVA COMMON 45781M101 279,616 38,157 4,824 0.0006
2022-02-10 2021-12-31 13F THESEUS PHARMACEUTICALS COMMON 88369M101 5,108 5,108 65 0.0000
2022-02-10 2021-12-31 13F INNOVIVA COMMON 45781M101 279,616 38,157 4,824 0.0006
2021-11-12 2021-09-30 13F INNOVIVA COMMON 45781M101 241,459 -91,656 -27.51 4,035 -9.67 0.0005
2021-08-12 2021-06-30 13F INNOVIVA COMMON 45781M101 333,115 133,692 67.04 4,467 87.45 0.0005
2021-05-12 2021-03-31 13F INNOVIVA COMMON 45781M101 199,423 50,784 34.17 2,383 29.37 0.0003
2021-02-19 2020-12-31 13F/A-1 INNOVIVA COMMON 45781M101 148,639 105,381 243.61 1,842 312.08 0.0003
2021-02-11 2020-12-31 13F INNOVIVA COMMON 45781M101 148,639 105,381 1,842 45.5540
2020-11-12 2020-09-30 13F/A-1 INNOVIVA COMMON 45781M101 43,258 -90,756 -67.72 447 -76.13 0.0001
2020-11-12 2020-09-30 13F INNOVIVA COMMON 45781M101 43,258 447
2020-08-11 2020-06-30 13F INNOVIVA COMMON 45781M101 134,014 102,663 327.46 1,873 406.22 0.0004
2020-05-12 2020-03-31 13F INNOVIVA COMMON 45781M101 31,351 -351 -1.11 370 -17.59 0.0001
2020-02-11 2019-12-31 13F INNOVIVA COMMON 45781M101 31,702 -158,402 -83.32 449 -77.59 0.0001
2019-11-12 2019-09-30 13F INNOVIVA COMMON 45781M101 190,104 16,104 9.26 2,004 -19.10 0.0004
2019-08-07 2019-06-30 13F INNOVIVA COMMON 45781M101 174,000 147,463 555.69 2,477 564.08 0.0005
2019-05-07 2019-03-31 13F INNOVIVA COMMON 45781M101 26,537 -51 -0.19 373 -19.61 0.0001
2019-02-11 2018-12-31 13F INNOVIVA COMMON 45781M101 26,588 -999,732 -97.41 464 -97.03 0.0001
2018-11-13 2018-09-30 13F/A-1 INNOVIVA COMMON 45781M101 1,026,320 659,372 179.69 15,641 208.93 0.0030
2018-11-07 2018-09-30 13F INNOVIVA COMMON 45781M101 1,026,320 659,372 15,641
2018-08-14 2018-06-30 13F INNOVIVA COMMON 45781M101 366,948 215,746 142.69 5,063 100.83 0.0010
2018-05-10 2018-03-31 13F INNOVIVA COMMON 45781M101 151,202 -272,428 -64.31 2,521 -58.06 0.0005
2018-02-13 2017-12-31 13F INNOVIVA COMMON 45781M101 423,630 -356,916 -45.73 6,011 -44.83 0.0013
2017-11-09 2017-09-30 13F INNOVIVA COMMON 45781M101 780,546 727,803 1,379.90 10,896 1,514.22 0.0024
2017-08-09 2017-06-30 13F INNOVIVA COMMON 45781M101 52,743 -67,584 -56.17 675 -59.44 0.0002
2017-05-10 2017-03-31 13F INNOVIVA COMMON 45781M101 120,327 -50,306 -29.48 1,664 -8.87 0.0004
2017-02-06 2016-12-31 13F INNOVIVA COMMON 45781M101 170,633 170,633 0.00 1,826 0.0004
2016-11-04 2016-09-30 13F INNOVIVA COMMON 45781M101 0 -7,024 -100.00 0 -100.00
2016-08-08 2016-06-30 13F INNOVIVA COMMON 45781M101 7,024 -6,960 -49.77 74 -57.95 0.0000
2016-05-10 2016-03-31 13F INNOVIVA COMMON 45781M101 13,984 980 7.54 176 28.47 0.0000
2016-02-12 2015-12-31 13F THERAVANCE COMMON 88338T104 13,004 13,004 137 -89.71 0.0000
2014-08-14 2014-06-30 13F THERAVANCE COMMON 88338T104 0 -16,110 -100.00 0 -100.00
2014-05-15 2014-03-31 13F THERAVANCE COMMON 88338T104 16,110 -623 -3.72 498 -16.44 0.0001
2014-02-26 2013-12-31 13F/A-1 THERAVANCE COMMON 88338T104 16,733 -74,244 -81.61 596 -83.97 0.0002
2014-02-13 2013-12-31 13F THERAVANCE COMMON 88338T104 16,733 596
2013-10-31 2013-09-30 13F THERAVANCE COMMON 88338T104 90,977 -13,257 -12.72 3,718 -7.42 0.0011
2013-08-13 2013-06-30 13F THERAVANCE COMMON 88338T104 104,234 104,234 4,016 0.0013
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-11-12 2020-09-30 13F/A INNOVIVA OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-11 2020-06-30 13F INNOVIVA OPTION Call 20,000 -93.75 280 -92.56 n/a n/a n/a
2020-05-12 2020-03-31 13F INNOVIVA OPTION Call 320,000 3,763 n/a n/a n/a
2016-11-04 2016-09-30 13F INNOVIVA OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-08 2016-06-30 13F INNOVIVA OPTION Call 38,700 -61.30 408 -67.59 n/a n/a n/a
2016-05-10 2016-03-31 13F INNOVIVA OPTION Call 100,000 1,259 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.